Deep Learning and Single-Cell Sequencing Analyses Unveiling Key Molecular Features in the Progression of Carotid Atherosclerotic Plaque.

Journal: Journal of cellular and molecular medicine
PMID:

Abstract

Rupture of advanced carotid atherosclerotic plaques increases the risk of ischaemic stroke, which has significant global morbidity and mortality rates. However, the specific characteristics of immune cells with dysregulated function and proven biomarkers for the diagnosis of atherosclerotic plaque progression remain poorly characterised. Our study elucidated the role of immune cells and explored diagnostic biomarkers in advanced plaque progression using single-cell RNA sequencing and high-dimensional weighted gene co-expression network analysis. We identified a subcluster of monocytes with significantly increased infiltration in the advanced plaques. Based on the monocyte signature and machine-learning approaches, we accurately distinguished advanced plaques from early plaques, with an area under the curve (AUC) of 0.899 in independent external testing. Using microenvironment cell populations (MCP) counter and non-negative matrix factorisation, we determined the association between monocyte signatures and immune cell infiltration as well as the heterogeneity of the patient. Finally, we constructed a convolutional neural network deep learning model based on gene-immune correlation, which achieved an AUC of 0.933, a sensitivity of 92.3%, and a specificity of 87.5% in independent external testing for diagnosing advanced plaques. Our findings on unique subpopulations of monocytes that contribute to carotid plaque progression are crucial for the development of diagnostic tools for clinical diseases.

Authors

  • Han Zhang
    Johns Hopkins University, Baltimore, MD, USA.
  • Yixian Wang
    Department of Vascular Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Mingyu Liu
    Department of Vascular and Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.
  • Yao Qi
    Department of Vascular Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Shikai Shen
    Department of Vascular Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Qingwei Gang
    Department of Vascular Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Han Jiang
    Second Affiliated Hospital, Nanchang University, Nanchang, China. jhan3939@sina.com.
  • Yu Lun
    Department of Vascular Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Jian Zhang
    College of Pharmacy, Ningxia Medical University, Yinchuan, NingxiaHui Autonomous Region, China.